Cassaday & Co Wealth Management LLC Sells 102 Shares of Aflac Incorporated (NYSE:AFL)

Cassaday & Co Wealth Management LLC trimmed its holdings in Aflac Incorporated (NYSE:AFL) by 2.4% in the 3rd quarter, Holdings Channel reports. The fund owned 4,235 shares of the financial services provider’s stock after selling 102 shares during the quarter. Cassaday & Co Wealth Management LLC’s holdings in Aflac were worth $473,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of AFL. Y.D. More Investments Ltd bought a new stake in Aflac in the second quarter worth $25,000. Covestor Ltd grew its stake in shares of Aflac by 41.8% in the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after acquiring an additional 107 shares during the period. Kennebec Savings Bank purchased a new position in shares of Aflac during the third quarter valued at approximately $45,000. Catalyst Capital Advisors LLC bought a new position in Aflac during the third quarter valued at approximately $51,000. Finally, Peterson Financial Group Inc. purchased a new stake in Aflac in the third quarter worth approximately $52,000. 67.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AFL has been the topic of several research analyst reports. Barclays began coverage on Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price target on the stock. Wells Fargo & Company raised their target price on Aflac from $106.00 to $107.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 5th. Morgan Stanley upped their price target on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. Evercore ISI raised their price objective on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a report on Thursday, September 26th. Finally, Truist Financial boosted their target price on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $97.93.

Aflac Price Performance

NYSE:AFL opened at $112.04 on Tuesday. The business’s 50-day simple moving average is $110.46 and its two-hundred day simple moving average is $99.89. Aflac Incorporated has a 52 week low of $75.07 and a 52 week high of $115.50. The stock has a market cap of $62.24 billion, a PE ratio of 16.87, a P/E/G ratio of 2.15 and a beta of 0.96. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. The business had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The company’s revenue was down 40.4% on a year-over-year basis. During the same period last year, the firm posted $1.84 EPS. As a group, analysts forecast that Aflac Incorporated will post 7.22 EPS for the current fiscal year.

Aflac Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.79%. The ex-dividend date is Wednesday, November 20th. Aflac’s payout ratio is currently 30.12%.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.